Mitochondrial DNA-boosted dendritic cell-based nanovaccination triggers antitumor immunity in lung and pancreatic cancers
Authors:
Open Access
- 9 July 2024
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 5 (7) , 101648
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT miceEuropean Journal of Immunology, 2021
- Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblastsAdvanced Drug Delivery Reviews, 2021
- Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110Cancer Letters, 2021
- Integrated Omics of Metastatic Colorectal CancerCancer Cell, 2020
- Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic CancerCancer Cell, 2020
- Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapyCancer Letters, 2019
- TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast CancerCancer Cell, 2018
- Bone Marrow Dendritic Cells Derived Microvesicles for Combinational Immunochemotherapy against TumorAdvanced Functional Materials, 2017
- Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and SpreadCancer Cell, 2015
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumoursThe Journal of Pathology, 2013